Fatty Acid Synthesis and Regulation

Historical Context & Motivation

The question of how living organisms manufacture fat from dietary carbohydrates fascinated biochemists long before the enzymatic machinery was identified. Early metabolic tracer experiments in the mid-twentieth century revealed that the pathway for fatty acid synthesis (lipogenesis) is distinct from β-oxidation, the catabolic route that degrades fatty acids. This observation overturned the simplistic assumption that biosynthesis was merely the reverse of degradation, and it launched decades of research into the enzymes, coenzymes, and regulatory mechanisms that govern de novo lipogenesis. Understanding these discoveries in chronological order clarifies why the pathway operates the way it does and why its regulation is so medically relevant.

These discoveries converged on a central question that still drives research today: how does a cell coordinate the energetically expensive production of fatty acids with the availability of substrates and the organism's overall energy balance? Answering that question requires a detailed understanding of the enzymatic steps of de novo synthesis, the transport of carbon from mitochondria to the cytosol, and the multilayered regulatory circuits—allosteric, covalent, and transcriptional—that modulate pathway flux.

Core Principles of Fatty Acid Synthesis

De novo fatty acid synthesis converts excess acetyl-CoA into the 16-carbon saturated fatty acid palmitate (C16:0) in the cytosol of hepatocytes and adipocytes. The pathway consumes ATP, NADPH, and bicarbonate, and it relies on two key enzymes: acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). Several foundational ideas underpin the entire pathway.

The De Novo Fatty Acid Synthesis Pathway

The diagram above traces the carbon flow from the mitochondrial matrix to the cytosol and through the two committed enzymatic steps. Within the mitochondrion, acetyl-CoA—produced primarily from pyruvate dehydrogenase—condenses with oxaloacetate (OAA) via citrate synthase to form citrate. When the citric acid cycle is saturated (i.e., cellular ATP and NADH are abundant), citrate accumulates and is exported through the mitochondrial citrate transporter. In the cytosol, ATP-citrate lyase regenerates acetyl-CoA and OAA at the expense of one ATP. The OAA is recycled back to the mitochondrion as malate (via malate dehydrogenase) or converted to pyruvate by malic enzyme, generating one molecule of NADPH in the process. This NADPH contributes to the reductive power required by FAS, alongside the pentose phosphate pathway, which supplies the bulk of the remaining NADPH.

Fatty acid synthase itself is a remarkable homodimeric multifunctional enzyme in mammals (type I FAS), with each polypeptide chain harboring seven distinct catalytic domains plus an acyl carrier protein (ACP) domain bearing a phosphopantetheine prosthetic group. Intermediates remain covalently tethered to the ACP thiol throughout the elongation cycle, ensuring substrate channeling and high catalytic efficiency. The cycle repeats seven times, adding two carbons per round, and the final product—palmitoyl-ACP—is released as free palmitate by the thioesterase domain.

Stoichiometry and Energetics of Palmitate Synthesis

The overall stoichiometry of palmitate synthesis can be derived by summing the individual reactions of ACC and the seven FAS cycles. Understanding the energy cost clarifies why de novo lipogenesis is tightly regulated—it is one of the most ATP- and NADPH-intensive biosynthetic pathways in the cell.

The 14 NADPH molecules required per palmitate are supplied primarily by two sources: the oxidative phase of the pentose phosphate pathway (glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase generate 2 NADPH per glucose-6-phosphate oxidized) and the cytosolic malic enzyme reaction (1 NADPH per OAA recycled). Thus, lipogenesis links carbohydrate catabolism, the pentose phosphate shunt, and the citrate shuttle into a coordinated metabolic network.

Regulation of Fatty Acid Synthesis

Because palmitate synthesis is energetically expensive and occupies a pivotal position between carbohydrate and lipid metabolism, cells employ three tiers of regulation: allosteric, covalent (phosphorylation), and transcriptional. The primary regulatory target is ACC, the enzyme catalyzing the committed step.

Allosteric Regulation

Citrate, which accumulates when the TCA cycle is saturated, serves as a feed-forward allosteric activator of ACC. Binding of citrate induces the inactive protomeric form of ACC to polymerize into long, enzymatically active filamentous structures. Conversely, the end product palmitoyl-CoA promotes depolymerization and feedback inhibition, thereby preventing futile overproduction of fatty acids when cellular acyl-CoA pools are replete.

Covalent Modification (Phosphorylation)

The energy-sensing kinase AMP-activated protein kinase (AMPK) phosphorylates ACC at Ser79 (in mammals), inactivating the enzyme. AMPK is activated when the AMP:ATP ratio rises, signaling low cellular energy—a state incompatible with energy-consuming biosynthesis. Similarly, glucagon-stimulated protein kinase A (PKA) phosphorylates ACC during fasting. Insulin opposes these kinases by activating protein phosphatase 2A (PP2A), which dephosphorylates ACC and restores its activity. This hormonal axis ensures that lipogenesis is active in the fed state and suppressed during fasting or exercise.

Transcriptional Control

Long-term changes in lipogenic capacity are mediated by transcription factors. SREBP-1c (sterol regulatory element-binding protein 1c) is activated by insulin signaling and upregulates genes encoding ACC, FAS, ATP-citrate lyase, and stearoyl-CoA desaturase. A second transcription factor, ChREBP (carbohydrate-responsive element-binding protein), responds to high glucose flux and independently stimulates lipogenic gene transcription. Together, SREBP-1c and ChREBP integrate hormonal and nutrient signals to tune the cell's biosynthetic capacity over hours to days.

Worked Example: Calculating the Cost of Palmitate Synthesis

Let us work through the accounting of ATP and NADPH consumed in the synthesis of one molecule of palmitate from acetyl-CoA, starting from glucose as the carbon source.

Fatty Acid Synthesis vs. β-Oxidation

A common source of confusion in biochemistry is the relationship between fatty acid synthesis and β-oxidation. Although both pathways involve sequential two-carbon additions or removals, they are catalyzed by different enzymes, occur in different cellular compartments, use different cofactors, and are regulated reciprocally. The table below highlights the key distinctions.

Clinical Relevance and Advanced Connections

Dysregulation of fatty acid synthesis has direct clinical implications. In metabolic syndrome and non-alcoholic fatty liver disease (NAFLD), hepatic de novo lipogenesis is pathologically elevated due to chronic hyperinsulinemia and SREBP-1c overactivation. Conversely, pharmacological inhibition of FAS or ACC is being explored as a strategy to combat obesity and certain cancers where lipogenesis fuels rapid cell proliferation. The table below connects the biochemistry to advanced and clinical topics.

Looking forward, understanding de novo lipogenesis provides the biochemical foundation for courses in nutritional biochemistry, endocrinology, and pharmacology. The interplay between AMPK, mTORC1, and insulin signaling pathways illustrates how cells integrate growth signals with metabolic capacity, a theme that recurs throughout cell biology and molecular medicine.

Practice Problems

Fatty Acid Synthesis and Regulation — Summary